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Functional in vitro and in vivo reporter gene assays have
recently been developed for the rapid determination of
exposure to (xeno)estrogens. The in vitro estrogen receptor
(ER)-mediated chemically activated luciferase gene
expression (ER-CALUX) assay uses T47D human breast
cancer cells stably transfected with an ER-mediated luciferase
gene construct. In the in vivo assay, transgenic zebrafish
are used in which the same luciferase construct has
been stably introduced. In both assays, luciferase reporter
gene activity can be easily quantified following short-
term exposure to chemicals activating endogenous estrogen
receptors. The objective of this study was to compare
responses by known (xeno)estrogenic compounds in both
assays. Exposure to the (xeno)estrogens estradiol (E2),
estrone, ethynylestradiol (EE2), o,p′-DDT, nonylphenol (NP),
and di(2-ethylhexyl)phthalate (DEHP) revealed that EE2
was the most potent (xeno)estrogen tested and was 100
times more potent than E2 in the transgenic zebrafish assay,
whereas in the in vitro ER-CALUX assay, EE2 and E2
were equipotent. Although the xenoestrogens o,p′-DDT
and NP were full estrogen agonists in the in vitro ER-
CALUX assay, only o,p′-DDT demonstrated weak dose-related
estrogenic activity in vivo. To determine if differences in
reporter gene activity may be explained by differential affinity
of (xeno)estrogens to human and zebrafish ERs, full-
length sequences of the zebrafish ER subtypes R, â, and
ç were cloned, and transactivation by (xeno)estrogens was
compared to human ERR and ERâ. Using transiently
transfected recombinant ER and reporter gene constructs,
EE2 also showed relatively potent activation of zebrafish
ERR and ERâ compared to human ERR and ERâ. Zebrafish
ERâ and ERç showed higher transactivation by (xeno)-
estrogens relative to E2 than human ERâ.
Introduction
The presence of hermaphrodite fish has been increasingly
reported in wild fish populations in rivers, estuaries, and
coastal waters (1-4). These effects have been associated with
exposure of fish in the aquatic environment to natural and
xenobiotic compounds with the same mode of action as the
estrogen steroid hormones [the so-called ª(xeno)estrogensº].
The focus on (xeno)estrogens in the aquatic environment
can be largely attributed to the finding that effluents from
wastewater treatment plants (WTP) contain (xeno)estrogenic
chemicals, such as the natural estrogens 17â-estradiol (E2)
and estrone (E1), the synthetic estrogen 17R-ethynylestradiol
(EE2), and xenoestrogens such as the alkylphenol surfactants
at levels sufficient to invoke estrogenic effects in fish (reviewed
in ref 5). However, routine chemical analysis of (xeno)-
estrogens in complex mixtures such as WTP effluent is difficult
and hampered by high costs. Only known compounds are
included in the analysis, and no account is taken of the
biological effects of mixtures of chemicals. The use of
bioassays to rapidly screen the exposure and demonstrate
potential effects of (xeno)estrogens can provide an ideal
means to determine the total estrogenic potency of mixtures
of substances. Recently, extensive efforts to develop screening
assays to detect exposure of (xeno)estrogenic compounds
on wildlife have been undertaken (reviewed in refs 6 and 7).
In our laboratories, two new assays for estrogenic activity
have been recently developed: the in vitro estrogen receptor-
mediated chemically activated luciferase gene expression
(ER-CALUX) assay using human T47D breast cancer cells (8)
and the in vivo transgenic zebrafish assay (9). In both assays,
an ER-mediated luciferase reporter gene construct containing
three estrogen response elements (ERE) has been stably
introduced and integrated in the genome of the T47D cells
and transgenic zebrafish. In the ER-CALUX assay, exposure
of cells to (xeno)estrogens results in uptake of chemicals
through the cell membrane, binding to the endogenous ER,
activation of the receptor, and, consequently, binding of the
ligand-receptor complex to EREs present in the promoter
region of the luciferase gene. Luciferase protein is then
induced and is easily measured by lysing the cells, adding
luciferin substrate, and measuring light photon production.
In the transgenic zebrafish assay, luciferase is induced
according to the same principle, but exposure to test
substances takes place via the water phase. Therefore, the
environmental chemistry, bioavailability, and toxicokinetics
of the test substance in vivo determine the ultimate exposure
of target cells in the transgenic fish. Luciferase protein will
be induced only in target cells in which the test substance
is bioavailable and active endogenous ERs and cofactors
necessary for ER transcription are present. Therefore, the
response of target tissues and specific life stages to (xeno)-
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estrogen exposure can be determined in the transgenic
zebrafish.
The objective of this study was to compare and contrast
the in vitro ER-CALUX and in vivo transgenic zebrafish assays
as short-term screens for environmentally relevant (xeno)-
estrogens. As differential binding and activation of com-
pounds by human and zebrafish estrogen receptors may
explain differences in responses between the two assays,
transient transfection experiments were carried out with ER
R and ERâ subtypes cloned from both species, as well as the
novel zebrafish ERç subtype. The use of in vitro and in vivo
reporter gene assays as screens for estrogenic activity is
discussed.
Experimental Section
Test Chemicals. 17â-Estradiol (E2, 99%) and ethanol (100%,
p.a.) were purchased from Sigma Chemical Co. Estrone (E1,
p.a.) was from Brunschwig. Ethynylestradiol (EE2, 98%) was
purchased from Aldrich. 4-Nonylphenol (NP, 91%) and di-
(2-ethylhexyl)phthalate (DEHP, 98% purity) were from TCI,
Japan. The organochlorine insecticide o,p′-dichlorodiphenyl
trichloroethane (o,p′-DDT) was kindly provided by the Dutch
State Institute for Quality Control of Agricultural Products
(RIKILT-DLO). Dimethyl sulfoxide (DMSO, 99.9%, spectro-
photometric grade) was purchased from Acros.
ER-CALUX Assay. The development of the stably trans-
fected T47D cells and the ER-CALUX assay procedure is
described in detail elsewhere (8). Briefly, T47D.Luc cells stably
transfected with the DNA construct pEREtata-Luc containing
a luciferase reporter gene regulated by three tandem repeats
of the consensus ERE oligonucleotide (GAGCTTAGGTCACT-
GTGACCT) upstream of the minimal human E1B TATA
promoter sequence (GGGTATATAAT) were plated in clear
plastic 96 well plates (Nucleon). Cells were plated at a density
of 5000 cells per well in 0.1 mL of assay medium containing
DMEM-F12 without phenol red and 5% dextran-coated
charcoal-stripped fetal calf serum (DCC-FBS). Following 24
h of incubation, medium was renewed and the cells were
incubated for another 24 h. The medium was then removed,
and the cells were dosed in triplicate by addition of the dosing
medium containing the chemical dissolved in DMSO (maxi-
mum 0.2%). A complete E2 dose-response curve was
included with each assay. Control wells, solvent control wells,
and E2 calibration points (6 and 30 pM) were included in
triplicate on each plate. Following 24 h of treatment, cells
were lysed in 50 íL of Triton lysis buffer, pH 7.8 (containing
1% Triton X-100, 25 mM glycylglycin, 15 mM MgSO4, 4 mM
EGTA, and 1 mM DTT) for a minimum of 1 h with gentle
shaking at 4 °C. A sample of 25 íL of lysate was then
transferred to a black 96 well plate (Costar), and 25 íL of
luciferin solution (Luclite, Packard) was added per well.
Luciferase activity was assayed in a scintillation counter (Top
Count, Packard) for 0.1 min per well.
Transgenic Zebrafish Assay. The recent development of
the transgenic zebrafish stably expressing pEREtata-Luc is
described elsewhere (9). For the assays, heterozygous trans-
genic juveniles of the F4 generation of the age of 4-5 weeks
were used. Juvenile transgenic zebrafish undergoing gonad
differentiation were used because this period was previously
shown to be the most responsive to estrogens during
development (9). Juvenile fish (n ) 5-6) were exposed for
96 h in 200 mL of acclimated tap water (26-27 °C) in all-glass
aquaria. The chemical to be tested was added to the water
at a volume not exceeding 0.01% solvent. Fish were fed once
daily with live brine shrimp (Artemia salinas). Test medium
was renewed for 50% daily. After termination of the exposure,
fish were sacrificed, transferred to Eppendorf vials, and
immediately frozen at -80 °C. To assay luciferase, Eppendorf
vials containing fish were transferred to ice, 500 íL of cold
Triton lysis buffer was added, and the fish were homogenized
using a micropestle (Eppendorf). Following centrifugation
at 12000 rpm for 15 min at 4 °C, duplicate samples of 25 íL
of supernatant were assayed in a luminometer (LUMAC) with
automatic injection of 100 íL of luciferin substrate, pH 7.8
[containing 20 mM tricine, 1 mM (MgCO3)Mg(OH)2â5H2O,
2.67 mM MgSO4, 0.1 mM EDTA, 33.7 mM DTT, 270 íM
coenzyme A, 470 íM luciferin, and 530 íM ATP]. Light units
measured by the luminometer were normalized for protein
content, which was measured according to the method of
Bradford (10).
Human and Zebrafish ER Transactivation. The cloning
of full-length zebrafish (zf) ERR, zfERâ, and zfERç is described
elsewhere (Zeinstra et al., in preparation). The DNA sequences
of these receptors have been submitted to GenBank. The zf
ER constructs pSG5-zfERR, pSG5-zfERâ, and pSG5-zfERç
were constructed by insertion of the full-length zfERR, zfERâ,
and zfERä cDNAs into the EcoRI site of the multiple cloning
site of the pSG5 expression vector (Stratagene). Human ERR
expression plasmid pSG5-hERR HEGO was kindly provided
by Dr. P. Chambon, IGBMC, Strasbourg, France. Human ERâ
expression plasmid pSG5-hERâ was a kind gift from Dr. J. A.
Gustafsson, Karolinska Institute, Huddinge, Sweden. Trans-
activation of these receptor constructs by (xeno)estrogens
was tested in the human embryonic kidney (293HEK) cell
line, which was acquired from the American Type Culture
Collection (ATCC, Rockville, MD), essentially as described
elsewhere (11). Briefly, the 293HEK cells were plated at a
density of 35000 cells/cm2 in 24 well plates (Costar). After 30
h, cells were transiently transfected by calcium phosphate
precipitation using 0.8 íg of pEREtata-Luc (luciferase reporter
construct), 0.4 íg of pSV2LacZ (â-galactosidase expression
vector), 0.6 íg of Bluescript SK- (Stratagene), and 0.2 íg of
receptor construct for a total of 2.0 íg of DNA per well.
Medium was removed 16 h after transfection, and the cells
were dosed in triplicate by the addition of assay medium
containing the chemical to be tested dissolved in ethanol
(maximum 0.1%). Following 24 h of incubation, medium
was removed and cells were lysed in 150 íL of Triton lysis
buffer. Luciferase activity was assayed in a 50 íL sample with
the addition of 50 íL luciferin as described for the ER-CALUX
assay above. The â-galactosidase activity was measured to
correct for variation in transfection efficiency.
Analysis of Actual Exposure Concentrations. Test chemi-
cals were measured in exposure water in transgenic zebrafish
assays at the start (t ) 0) of an exposure experiment, prior
to introducing the transgenic zebrafish, as well as at the end
(t ) 96 h) of the experiment. Test medium samples were
100 mL. Although tissue hormone (E2, E1, and EE2)
concentrations could not be analyzed due to analytical
limitations, NP and o,p′-DDT levels were analyzed in whole
fish homogenates (n ) 5, total weight 100 mg) at the start
and termination of the experiment.
E2, E1, and EE2 analysis in water was carried out as
described in Belfroid et al. (12), with the exception that the
quantification of the chromatograms was done with the
internal deuterated standard of d4-17â-estradiol. For NP
analysis in test medium, water was extracted according to
the method described by De Voogt et al. (13). Analysis of NP
in zebrafish following 96 h of exposure was done according
to the method of Zhao et al. (14). Extracts were analyzed by
reversed-phase HPLC with fluorescence detection. For o,p′-
DDT analysis, exposure water samples were extracted three
times with n-hexane. As these samples were not filtered prior
to extraction, it is possible that o,p′-DDT bound to suspended
matter (e.g., detritus) in the water column was also extracted,
leading to concentrations apparently exceeding nominal
concentrations. The extracts were dried over anhydrous Na2-
SO3 and analyzed by GC-ECD. Zebrafish were mixed with
anhydrous Na2SO3 and then extracted three times with
acetone/n-hexane (1:3 v/v). The extract was then filtered
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and analyzed with GC-ECD. The extraction efficiency of o,p′-
DDT was 90-100%.
Data Analysis. Data shown are representative of a
minimum of three independent experiments. In the figures,
values represent averages of three test wells for in vitro
experiments and five to six fish per concentration for the
transgenic zebrafish assay. The EC50 values for the ER-CALUX,
transient transfections with human and zebrafish ER con-
structs, and transgenic zebrafish assays were calculated from
sigmoid dose-response curves using the curve-fitter of
SlideWrite for Windows, version 4.0 (cumulative fit). The R
of the fit of the curves was >0.99 for the in vitro assays and
>0.9 for the transgenic zebrafish assay. EC50 values were
calculated by determining the concentration at which 50%
of the maximum luciferase activity was reached. Estradiol
equivalent factors (EEF) were determined as the ratio EC50(E2)/
EC50(test compd). EEQ and EEF values were calculated on the
basis of an average of three to five independent experiments.
Results and Discussion
ER-CALUX and Transgenic Zebrafish Assay Characteristics.
The in vitro ER-CALUX assay using stably transfected T47D
cells can detect estradiol (E2) at concentrations as low as 0.5
pM and demonstrates an EC50 of 6 pM, with a coefficient of
variation of 5%. Maximal induction (100-fold relative to
solvent controls) is reached at 30 pM E2. The in vivo transgenic
zebrafish assay using 96-h-exposed juvenile transgenics has
a detection limit of 300 pM E2 and an EC50 of 10 nM and
exhibits higher variation (CV ) 20-30%). Maximal fold
induction of 1000-3000-fold relative to solvent controls is
reached at 100 nM E2. The high biological variation is a
reflection of individual fish differences in uptake and
metabolism of substances, as well as differences in (gonad)
developmental stage and sex. As the phenotypic sex of the
transgenic zebrafish is not apparent at the age of fish used,
both males and females are assayed together, thereby
contributing to the variation in response. Previous studies
have reported that male and female transgenics respond
differently to E2 exposure (9). Interestingly, a decrease of
luciferase activity by high concentrations of (xeno)estrogens
can be seen in both assays, particularly in the transgenic
zebrafish assay (Figure 1). Down-regulation of ERs or other
mechanisms of negative feedback or sublethal toxicity to
high doses may cause this decrease.
Relative Responses of the Screening Assays to (Xeno)-
estrogens. The ER-CALUX and transgenic zebrafish reporter
gene assays demonstrated a dose-response-related increase
in luciferase protein expression following exposure to es-
tradiol (E2), estrone (E1), and ethynylestradiol (EE2) (Figure
1). However, the sensitivities of the responses of the two
assays differ, and the relative potencies of (xeno)estrogens
vary according to the assay used (Table 1). In the ER-CALUX
assay, the EC50 values of E2 and E1 were 2-3 orders of
magnitude lower than in the transgenic zebrafish (Table 1).
E1 induced luciferase in the transgenic zebrafish at similar
concentrations as E2 (EEF ) 1; Table 1). In the ER-CALUX
assay, however, E1 was considerably less potent than E2,
with an EEF of 0.2 (Table 1). The apparent higher in vivo
potency of E1 relative to E2 in the fish as compared to the
in vitro assay has been reported previously. In a recent study,
Panter and colleagues (15) demonstrated that E1 induced
vitellogenin at concentrations similar to E2 in male fathead
minnows. Routledge and colleagues (16) also showed that
E1 was only slightly less potent than E2 in inducing
vitellogenin in rainbow trout. In both assays, EE2 was the
most potent (xeno)estrogen tested with only a 20-fold
difference in EC50 between the ER-CALUX (0.005 nM) and
transgenic zebrafish (0.1 nM) assays (Table 1; Figure 1).
Interestingly, in the transgenic fish, EE2 was 100 times more
potent than E2, whereas in the ER-CALUX, EE2 was slightly
(1.2 times) more potent (Table 2). The high estrogenic activity
of EE2 to zebrafish has also been demonstrated in other fish
species, such as the medaka (17) and fathead minnow (18),
providing even more evidence that the presence of this
compound in aquatic environments is of particular concern.
Another dramatic difference in response between the ER-
CALUX and transgenic zebrafish assay was found with
exposure to xenoestrogenic chemicals. The organochlorine
pesticide o,p′-DDT induced luciferase activity in a full dose-
FIGURE 1. Estrogenic potency of (xeno)estrogens estradiol (E2, b),
estrone (E1, O), ethynylestradiol (EE2, 2), o,p′-DDT (3), 4-nonylphenol
(NP, 0), and DEHP ([) in (A) in vitro ER-CALUX and (B) in vivo
transgenic zebrafish reporter gene assays. Data are representative
of three independent assays. Values given are average percentage
luciferase activity relative to maximal response levels induced by
E2; error bars represent standard error of the mean (ER-CALUX, n
) 3; transgenic zebrafish, n ) 5-6).
TABLE 1. Estrogenic Potency of (Xeno)estrogens in in Vitro
ER-CALUX and in Vivo Transgenic Zebrafish Assays
ER-CALUX transgenic zebrafish
compd EC50a (nM) EEFb EC50a (nM) EEFb
E2 0.006 1 10 1
EE2 0.005 1.2 0.1 100
E1 0.06 0.1 10 1
o,p′-DDT 390 1.5  10-5 450 0.02
NP 260 2.3  10-5 >1000c <0.01
DEHP >30000c <2.0  10-7 >5000c <0.05
a EC50 is nominal concentration at which 50% of maximal response
is reached. b EEF is the ratio EC50(E2)/EC50(compd). c EC50 could not be
calculated as no or minimal luciferase induction was observed; higher
concentrations caused (cyto)toxicity.
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dependent manner in the ER-CALUX and showed weak
estrogenic activity in the transgenic zebrafish assay (Figure
1; Table 1). However, exposure to nonylphenol (NP) only
slightly induced luciferase in transgenic zebrafish (13-fold
induction at 1000 nM or 1% of the response of 10 nM E2),
whereas it was a full agonist in the ER-CALUX assay (Figure
1). The modest response of the transgenic zebrafish to NP
is surprising, as a number of reports have documented the
in vivo estrogenicity of nonylphenol in other fish species
(reviewed in ref 5). NP has been shown to induce vitello-
genesis and inhibition of testicular growth in male rainbow
trout exposed under continuous flow conditions for 3 weeks
(19) as well as to induce feminized gonads in male Japanese
medaka exposed during a full life cycle (3 months) (20).
Although it is possible that the 96-h-exposure duration of
the transgenic zebrafish was too short to achieve an internal
dose that could induce luciferase, prolonged (3 week)
exposure to NP also did not result in increased luciferase
expression in juvenile transgenic zebrafish (unpublished
results). Accordingly, a recent study has shown that despite
the high sensitivity of zebrafish to ethynylestradiol, exposure
to the alkylphenol 4t-octylphenol failed to induce vitello-
genesis in zebrafish (21). These results indicate that zebrafish
may show a different sensitivity to alkyphenols than other
fish species.
The phthalate DEHP demonstrated very weak estrogenic
potency in both the ER-CALUX and the transgenic zebrafish
assay (Figure 1). In the ER-CALUX assay, 10000 nM DEHP
induced luciferase 13 times above solvent controls (or 13%
of maximal E2 levels). In the transgenic zebrafish assay, 5000
nM (nominal) DEHP induced luciferase 20 times above
solvent controls (or 2% luciferase activity relative to 10 nM
E2). To our knowledge, specific estrogenic effects of DEHP
in fish in vivo have not been demonstrated previously,
although the rapid metabolism of DEHP in rainbow trout
has been shown (22). In mammals, a recent study has shown
the inability of DEHP to induce estrogenic activity (i.e.,
increase uterine wet weight) in rats in vivo (23). These studies,
taken together with our results, suggest that DEHP may not
exert estrogenic effects in fish at levels found in the aquatic
environment.
Relative Differences in Transactivation Potential of
Human and Zebrafish ERs. The large differences in potency
of (xeno)estrogens between the in vitro and in vivo assays
may be explained in part by the differential potency of (xeno)-
estrogens to activate human and zebrafish ERs. Species-
specific differences in response may occur due to differences
in transcription factors and the cellular context regulating
ER binding and transactivation (24). To investigate these
differences, we cloned zebrafish ER R and â subtypes, as well
as a zfER ç subtype, which was recently demonstrated for
the first time in the marine fish Atlantic croaker (25). Zebrafish
and human ERs were compared using transient transfection
experiments in a human embryonic cell line, which is easily
transfected and devoid of steroid hormone receptors and
basal metabolic capacity and has been shown previously to
be highly responsive to estrogens when recombinant receptor
and reporter gene constructs are transfected (11). All test
compounds induced dose-response-related luciferase ac-
tivity in HEK293 cells transiently tranfected with ER constructs
(Figure 2). When results by E2 exposure were compared,
zebrafish ERR was 40 times less sensitive to E2 than human
ERR, whereas zebrafish ERâ showed 6 times less sensitivity
relative to human ERâ (Table 2). Accordingly, rainbow trout
ER has been shown to require 10 times higher E2 concentra-
tions than the human ER for transactivation (26, 27). Although
the zebrafish ERs demonstrated a lower transactivational
potential following estrogen exposure as compared to human
ERs, an interesting difference was observed in the relative
potency for E2 between human and fish ERâ subtypes. E2
transactivated zebrafish ERR and ERâ at similar concentra-
tions, whereas a 10-fold excess of E2 was required to
transactivate human ERâ both in this study (Table 2) and in
others (28). These results suggest that the ERâ subtype in
zebrafish may be relatively more sensitive to (xeno)estrogens
than the human ERâ. In addition, zebrafish ERç was activated
by the lowest E2 concentrations of the three zebrafish receptor
subtypes (EC50 ) 0.13 nM; Table 2), suggesting the important
role of this receptor in estrogen regulation in fish. Estrone
transactivated both human and zebrafish ERR and ERâ at
similar potency relative to E2 (Table 2). The high activity of
EE2 shown in the in vivo transgenic zebrafish assay was also
observed in the in vitro transfection assays in which a
relatively high transactivation potential of EE2 was found;
EE2 was up to 4 times more potent than E2 in transactivating
zebrafish ER R, â, and ç subtypes (Table 2). Accordingly, in
TABLE 2. Estrogenic Potency of (Xeno)estrogens To Transactivate (A) Human ERr and ERâ and (B) Zebrafish ERr, ERâ, and ERça
A, Human ER
human ERr human ERâ
compd EC50b (nM) EEFc EC50b (nM) EEFc
E2 0.009 1 0.08 1
EE2 0.008 1.1 0.14 0.6
E1 0.08 0.1 0.65 0.1
o,p′-DDT 230 3.9  10-5 700 1.1  10-4
NP 110 8.2  10-5 145 5.5  10-4
DEHP >30000c <3.0  10-7 >30000c <3.0  10-7
B. Zebrafish ER
zebrafish ERr zebrafish ERâ zebrafish ERç
compd EC50b (nM) EEFc EC50b (nM) EEFc EC50b (nM) EEFc
E2 0.38 1.0 0.50 1.0 0.10 1.0
EE2 0.10 3.8 0.10 5.0 0.04 2.5
E1 1.01 0.4 4.08 0.1 1.14 0.1
o,p′-DDT 1800 2.1  10-4 5010 9.9  10-5 2050 4.9  10-5
NP 420 9.0  10-4 1480 3.4  10-4 670 1.5  10-4
DEHP >30000d <1.3  10-5 >30000d <1.3  10-5 NAe NA
aHuman 293HEK embryonic kidney cells were transiently transfected with recombinant human and zebrafish ER DNA constructs together with
the luciferase reporter gene PERE-tata-Luc. b EC50 is nominal concentration at which 50% of maximal response is reached. c EEF is the ratio
EC50(E2)/EC50(compd). d EC50 could not be calculated as no or minimal luciferase induction was observed; higher concentrations caused (cyto)toxicity.
e NA ) not analyzed.
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binding studies with channel catfish ER, EE2 was found to
be 5 times more active than E2 (29). The xenoestrogens tested
showed similar weak agonistic (o,p′-DDT, NP) or lack of
(DEHP) estrogenic activity in ERs from both species. Inter-
estingly, NP did induce dose-response-related transacti-
vation of all three zebrafish ERs (Figure 2b), indicating that
the lack of response of the transgenic zebrafish to NP may
be due to other factors (see below).
Differences in Target Cell Exposure in the Screening
Assays. In addition to differences at the receptor level,
differences in reporter gene activity following exposure to
(xeno)estrogens between the in vitro ER-CALUX screening
assay and the in vivo transgenic zebrafish assay may also be
explained by the lower actual target cell exposure in the
transgenic fish. Target cell concentrations depend on the
biotransformation and toxicokinetics of the compound in
the fish as well as its fate in the aquarium. In vivo, natural
estrogens as well as NP can be extensively transformed to
less potent metabolites by fish (30, 31). Therefore, in the
transgenic zebrafish, higher concentrations of E2, E1, or NP
may be required to induce luciferase in target cells. In the
ER-CALUX assay, biotransformation during the 24-h-
exposure period is likely to be much lower. The high potency
of ethynylestradiol in vivo in the transgenic zebrafish may
be partly due to its higher persistence in vivo compared to
E2 and E1, as it is poorly metabolized by the liver and subject
to intensive enterohepatic recycling (32). The lipophilic
compound o,p′-DDT was found in extremely high levels in
fish tissues following the 96-h-exposure period (>600 íg/kg;
Table 3), indicating that bioaccumulation potential is also
an important factor in predicting differences between in vitro
and in vivo responses.
In addition to differences in biotransformation and
toxicokinetics of the test compounds, the strategy for dosing
chemicals differs greatly between the two assays. In the ER-
CALUX assay, chemicals are added to sterile medium
containing serum with lipids and proteins, which will mediate
the cellular availability and membrane transport of test
chemicals. In the transgenic zebrafish assay, chemicals are
added directly to water and may rapidly disappear from the
water column due to sorption on glass, fish, and detritus as
well as biodegradation, resulting in large deviations between
nominal and actual test concentrations. Indeed, with the
exception of o,p′-DDT, chemical analysis of actual test
compound levels in exposure water revealed that although
actual concentrations were similar to nominal concentrations
at the beginning of the experiment, very low amounts of the
(xeno)estrogens were present after 96 h of exposure, despite
daily renewal of the exposure water (Table 3). In the case of
o,p′-DDT, actual concentrations were higher at the end of
the 96-h-exposure period, which can be explained by the
liquid-liquid extraction procedure used for DDT analysis in
contrast to the solid phase extraction procedure used for the
other test chemicals. DDT absorbed to particles in the water
column will also be extracted, leading to an overestimation
of the amount of dissolved o,p′-DDT. Despite the difficulty
in maintaining constant aqueous concentrations of test
chemicals, a static renewal experimental design has been
widely used for toxicity testing and has definite advantages
because it allows rapid, inexpensive, and easy screening of
chemicals in virtually any laboratory situation. However, an
experimental design using a flow-through system with
continuous dosing of chemicals will likely result in higher
FIGURE 2. Transactivation of (A) human estrogen receptor r and â and (B) zebrafish estrogen receptors r, â, and ç by (xeno)estrogens
estradiol (E2, b), estrone (E1, O), ethynylestradiol (EE2, 2), o,p′-DDT (3), and 4-nonylphenol (NP, 0). Human HEK293 cells were transiently
transfected with human or zebrafish ER and luciferase reporter gene constructs. Data are the average of two to three independent assays.
Values given are mean; error bars represent standard error of the mean (n ) 3).
TABLE 3. Concentrations of (Xeno)estrogens Determined in
Test Water and Fish Taken during Exposure Experiments with
Transgenic Zebrafisha
measured concn
nominal concn,
water
water
(íg/L)
transgenic
zebrafish (íg/kg)
compd nM íg/L t ) 0 t ) 96 h t ) 0 t ) 96 h
E2 100 27 20.3 1 NAb
EE2 1 0.3 0.4 <dlc NA
E1 100 27 30 0.2 NA
NP 1000 220 133 7 <dl 8940
o,p′-DDT 1000 346 340 850 <dl 685000
aSamples were taken at the start (t ) 0) and end (t ) 96 h) of the
experiment. b NA ) not analyzed. c <dl ) below detection limit.
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sensitivity to test compounds, as well as actual test con-
centrations which more realistically reflect nominal con-
centrations. To this end, more frequent measurements of
actual test concentrations during the exposure period are
also recommended.
Use of in Vitro and in Vivo Reporter Gene Assays To
Screen Estrogenic Activity. Both the in vitro ER-CALUX assay
and the in vivo transgenic zebrafish assay have a number of
characteristics that make them useful screening models. The
ER-CALUX assay is extremely sensitive and rapid and can be
used to screen many chemicals in a high-throughput manner.
The ER-CALUX assay is a suitable choice for screening new
and existing chemicals, as well as complex environmental
samples for unexpected estrogenic activity that may be further
identified by chemical analysis. The high sensitivity of the
ER-CALUX assay minimizes the potential for false-negative
results. However, false-positives may occur primarily due to
the fact that an in vitro assay may poorly predict the
toxicokinetics of a substance in vivo, as was shown in this
study for EE2 and o,p′-DDT. In addition, differential receptor
activation and ligand specificity was observed between
human and zebrafish ERs, emphasizing the need for het-
erologous systems for risk assessment purposes. For these
reasons, the in vivo transgenic zebrafish assay can form an
excellent complement to the ER-CALUX assay. The assay is
rapid (96 h) and easy to perform, and the measured endpoint
(luciferase activity) is simple and cost-effective. The value of
the transgenic zebrafish assay is that it can predict if
estrogenic activity measured with an in vitro assay actually
may affect fish during a critical life stage, for example, the
stage of gonad differentiation. When adult transgenic fish
are used, it is possible to determine the tissue-specific effects
of (xeno)estrogens (9). The transgenic zebrafish assay may
be used to further direct and fine-tune costly long-term
exposure studies in which reproductive and histological
parameters are analyzed. Ideally, biological validation of the
ER-CALUX and transgenic zebrafish assays will reveal critical
levels of reporter gene induction that correspond with
estrogenic effects on gonad differentiation and reproduction
in the zebrafish.
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